{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:56:01Z","timestamp":1759179361724},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T00:00:00Z","timestamp":1478044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T00:00:00Z","timestamp":1478044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Either acute or sub-acute Budd\u2013Chiari syndrome (BCS) with diffuse occlusion of hepatic veins has a high mortality rate and remains challenging for clinical treatment. We aimed to evaluate the feasibility and safety of transjugular intrahepatic portosystemic shunt (TIPS) as a treatment for BCS with diffuse occlusion of hepatic veins. From January 2007 to December 2010, 100 patients were randomly recruited onto this study and 91 patients were treated with TIPS. 14 patients were defined as acute BCS group and 86 patients as sub-acute group. Patients with acute BCS had a significantly higher rate of jaundice whereas a lower rate of abdominal and chest varices, gastroesophageal variceal bleeding and refractory ascites than sub-acute group (P\u2009&lt;\u20090.001). TIPS was technically successful in all 91 patients (12 in acute group). The portosystemic pressure gradient (PSG) was decreased to normal level, while total bilirubin (TBIL) and liver function were significantly improved. During follow-up period, the mortality rate of 91 patients who underwent TIPS was 6.59% (6\/91), whereas 88.89% of 9 patients who didn\u2019t receive TIPS procedure (2 in acute group). Collectively, TIPS is an effective and safe approach in treating BCS with diffuse occlusion of hepatic veins, which should be performed in time.<\/jats:p>","DOI":"10.1038\/srep36380","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T11:12:33Z","timestamp":1478085153000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Transjugular intrahepatic portosystemic shunt for Budd\u2013Chiari syndrome with diffuse occlusion of hepatic veins"],"prefix":"10.1038","volume":"6","author":[{"given":"Fuliang","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongdong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhendong","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuquan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,2]]},"reference":[{"key":"BFsrep36380_CR1","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1111\/liv.12828","volume":"35","author":"A Potthoff","year":"2015","unstructured":"Potthoff, A. & Bahr M. J. Response to Time to resize the role of liver transplant for Budd-Chiari syndrome. Liver Int 35, 2339 (2015).","journal-title":"Liver Int"},{"key":"BFsrep36380_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s00261-014-0193-y","volume":"40","author":"D Cheng","year":"2015","unstructured":"Cheng, D. et al. Comparative study of MRI manifestations of acute and chronic Budd-Chiari syndrome. Abdom Imaging 40, 76\u201384 (2015).","journal-title":"Abdom Imaging"},{"key":"BFsrep36380_CR3","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.3748\/wjg.v21.i8.2413","volume":"21","author":"FL He","year":"2015","unstructured":"He, F. L. et al. Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome. World J Gastroenterol 21, 2413\u20132418 (2015).","journal-title":"World J Gastroenterol"},{"key":"BFsrep36380_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/liv.12544","volume":"34","author":"A Mancuso","year":"2014","unstructured":"Mancuso, A. TIPS for Budd-Chiari syndrome: time to anticipate treatment. Liver Int 34, 325 (2014).","journal-title":"Liver Int"},{"key":"BFsrep36380_CR5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1136\/postgradmedj-2015-133402","volume":"91","author":"RM Goel","year":"2015","unstructured":"Goel, R. M., Johnston, E. L., Patel, K. V. & Wong, T. Budd-Chiari syndrome: investigation, treatment and outcomes. Postgrad Med J 91, 692\u2013697 (2015).","journal-title":"Postgrad Med J"},{"key":"BFsrep36380_CR6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/MEG.0000000000000621","volume":"28","author":"K Rosenqvist","year":"2016","unstructured":"Rosenqvist, K. et al. Endovascular treatment of symptomatic Budd-Chiari syndrome - in favour of early transjugular intrahepatic portosystemic shunt. Eur J Gastroenterol Hepatol 28, 656\u2013660 (2016).","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"BFsrep36380_CR7","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3109\/00365521.2013.777775","volume":"48","author":"X Qi","year":"2013","unstructured":"Qi, X., Yang, M., Fan, D. & Han, G. Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome: a critical review of literatures. Scand J Gastroenterol 48, 771\u2013784 (2013).","journal-title":"Scand J Gastroenterol"},{"key":"BFsrep36380_CR8","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/apt.12668","volume":"39","author":"D Tripathi","year":"2014","unstructured":"Tripathi, D. et al. Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome. Aliment Pharmacol Ther 39, 864\u2013872 (2014).","journal-title":"Aliment Pharmacol Ther"},{"key":"BFsrep36380_CR9","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jhep.2013.06.014","volume":"59","author":"M R\u00f6ssle","year":"2013","unstructured":"R\u00f6ssle, M. TIPS: 25 years later. J Hepatol 59, 1081\u20131093 (2013).","journal-title":"J Hepatol"},{"key":"BFsrep36380_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/j.1572-0241.2003.07515.x","volume":"98","author":"M Schepke","year":"2003","unstructured":"Schepke, M. et al. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol 98, 1167\u20131174 (2003).","journal-title":"Am J Gastroenterol"},{"key":"BFsrep36380_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1051-0443(07)61932-0","volume":"13","author":"DK Rajan","year":"2002","unstructured":"Rajan, D. K., Haskal, Z. J. & Clark, T. W. Serum bilirubin and early mortality after transjugular intrahepatic portosystemic shunts: results of a multivariate analysis. J Vasc Interv Radiol 13, 155\u2013161 (2002).","journal-title":"J Vasc Interv Radiol"},{"key":"BFsrep36380_CR12","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.3748\/wjg.v13.i19.2693","volume":"13","author":"M Aydinli","year":"2007","unstructured":"Aydinli, M. & Bayraktar, Y. Budd-Chiari syndrome: etiology, pathogenesis and diagnosis. World J Gastroenterol 13, 2693\u20132696 (2007).","journal-title":"World J Gastroenterol"},{"key":"BFsrep36380_CR13","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/hep.22772","volume":"49","author":"LD DeLeve","year":"2009","unstructured":"DeLeve, L. D. et al. Vascular disorders of the liver. Hepatology 49, 1729\u20131764 (2009).","journal-title":"Hepatology"},{"key":"BFsrep36380_CR14","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/bjh.12059","volume":"159","author":"H Watson","year":"2012","unstructured":"Watson, H. et al. Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition. Br J Haematol 159, 528\u2013540 (2012).","journal-title":"Br J Haematol"},{"key":"BFsrep36380_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0168-8278(12)60004-X","volume":"56","author":"A Plessier","year":"2012","unstructured":"Plessier, A., Rautou, P. E. & Valla, D. C. Management of hepatic vascular diseases. J Hepatol 56, 25\u201338 (2012).","journal-title":"J Hepatol"},{"key":"BFsrep36380_CR16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00270-013-0697-9","volume":"37","author":"K Fitsiori","year":"2014","unstructured":"Fitsiori, K. et al. Transjugular intrahepatic portosystemic shunt for the treatment of Budd-Chiari syndrome patients: results from a single center. Cardiovasc Intervent Radiol 37, 691\u2013697 (2014).","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep36380.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep36380","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep36380.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T09:18:44Z","timestamp":1718875124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep36380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,2]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,21]]}},"alternative-id":["BFsrep36380"],"URL":"https:\/\/doi.org\/10.1038\/srep36380","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,2]]},"assertion":[{"value":"2 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36380"}}